| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2022 | SERA Sera Prognostics, Inc. | Boniface John J.55 | Chief Scientific Officer | Sell | 2,725 | $1.30 | $3,542.50 | -4.0% | +30.0% | +146.2% | |
| Jun 7, 2022 | BDX Becton Dickinson & Co | Spoerel Thomas J58 | VP Controller &Chief Acct Off | Sell | 443 | $260.00 | $115,180.00 | -29.5% | -1.9% | -0.8% | |
| Jun 7, 2022 | CTKB Cytek Biosciences, Inc. | Jiang Wenbin75 | President And CEO | Sell | 20,000 | $10.75 | $215,000.00 | -0.3% | +14.0% | -24.6% | |
| Jun 7, 2022 | TELA Tela Bio, Inc. | Cuca Roberto50 | COO And CFO | Buy | 15,000 | $5.50 | $82,500.00 | +75.4% | +60.3% | +93.9% | |
| Jun 7, 2022 | INFU Infusystem Holdings, Inc | Ruiz Thomas Mark46 | Chief Commercial Officer | Sell | 15,000 | $9.88 | $148,200.00 | -31.3% | -23.8% | -10.5% | |
| Jun 7, 2022 | TELA Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P.57 | See Footnote 2 | Buy | 15,000 | $6.13 | $91,900.00 | +0.1% | +60.3% | +93.9% | |
| Jun 6, 2022 | RBOT Vicarious Surgical Inc. | Liang Philip45 | Director | Sell | 20,000 | $4.56 | $91,290.00 | -1.6% | -21.4% | -53.0% | |
| Jun 6, 2022 | DXCM Dexcom Inc | Sylvain Jereme M65 | EVP Chief Financial Officer | Sell | 600 | $301.57 | $180,942.00 | -3.3% | +10.7% | +69.2% | |
| Jun 6, 2022 | ATR Aptargroup, Inc. | Touya Gael61 | Segment President | Sell | 59,072 | $108.98 | $6,437,543.38 | -39.9% | -7.8% | +5.4% | |
| Jun 6, 2022 | PODD Insulet Corp | Alpuche Charles64 | EVP &Chief Operating Officer | Sell | 6,000 | $215.32 | $1,291,920.00 | -12.0% | +17.8% | +34.7% | |
| Jun 6, 2022 | VREX Varex Imaging Corp | Naumann-Etienne Ruediger | Director | Sell | 5,207 | $22.62 | $117,782.34 | -16.5% | -6.5% | -0.2% | |
| Jun 6, 2022 | CTSO Cytosorbents Corp | Bloch Kathleen P. | Chief Financial Officer | Buy | 8,700 | $1.90 | $16,529.13 | +34.8% | -4.2% | +75.8% | |
| Jun 3, 2022 | RMD Resmed Inc | Pendarvis David68 | Chief Administrative Officer | Sell | 1,545 | $209.44 | $323,584.80 | -1.4% | +5.6% | +6.3% | |
| Jun 3, 2022 | MMSI Merit Medical Systems Inc | Millner F. Ann49 | Director | Sell | 6,378 | $61.92 | $394,925.76 | -18.7% | -5.4% | +36.2% | |
| Jun 3, 2022 | RPID Rapid Micro Biosystems, Inc. | Kennedy Lewis Management LP | 10% Owner | Buy | 60,100 | $4.72 | $283,596.68 | +0.6% | -25.9% | -77.2% | |
| Jun 3, 2022 | LAB Standard Biotools Inc. | Caligan Partners LP58 | 10% Owner | Buy | 450,000 | $1.95 | $879,000.00 | +2.2% | -27.4% | +20.3% | |
| Jun 2, 2022 | LFWD Lifeward Ltd. | Lind Global Fund II LP47 | - | Buy | 236,616 | $1.00 | $236,497.69 | +3.2% | +1.0% | -39.8% | |
| Jun 2, 2022 | HAE Haemonetics Corp | Goldstein Dan | VP, Corporate Controller | Sell | 249 | $62.69 | $15,609.81 | -5.3% | +16.9% | +37.3% | |
| Jun 2, 2022 | Fry John J83 | General Counsel &Secretary | Sell | 378 | $17.47 | $6,605.02 | -1.0% | -46.8% | +15.8% | ||
| Jun 2, 2022 | Hrusovsky E Kevin86 | Executive Chairman | Sell | 712 | $17.47 | $12,441.20 | - | -46.8% | +15.8% | ||
| Jun 2, 2022 | HAE Haemonetics Corp | Miller Laurie A. | SVP, Human Resources | Sell | 198 | $62.69 | $12,412.62 | -1.5% | +16.9% | +37.3% | |
| Jun 2, 2022 | TELA Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P.57 | See Footnote 2 | Buy | 15,000 | $6.99 | $104,900.00 | +0.1% | +20.3% | +51.3% | |
| Jun 1, 2022 | EW Edwards Lifesciences Corp | Wood Larry L67 | Cvp, Tavr | Sell | 7,242 | $100.53 | $728,052.83 | -1.7% | -7.1% | -12.4% | |
| Jun 1, 2022 | IVF Invo Fertility, Inc. | Davis Trent D | Director | Buy | 11,184 | $0.95 | $10,624.80 | +49.8% | +1.1% | -77.5% | |
| Jun 1, 2022 | STIM Neuronetics, Inc. | Cannell Capital LLC69 | 10% Owner | Buy | 10,000 | $2.69 | $26,900.00 | +0.3% | +37.5% | +3.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.